Medico-economic Evaluation of Therapeutic Adaptation Guided by the Soluble Suppression of Tumorigenicity 2 (sST-2) Biomarker in the Management of Patients With Acute Heart Failure
Clinical trial NCT04554277 · RECRUITING
Trial details
- NCT number
- NCT04554277
- Sponsor
- University Hospital, Montpellier
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-27
- Primary completion
- 2026-04-27
- Enrollment
- 710
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.